Soranib 200 mg Cipla
€54.00
What is Soranib 200 mg Cipla? – Product introduction
Soranib 200 mg Cipla is a pharmaceutical product that contains the active ingredient Sorafenib. This medication is primarily used in the treatment of cancer, specifically targeting advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma. Sorafenib functions as a multi-kinase inhibitor, blocking several enzymes that promote tumor growth and blood vessel formation in cancerous tissues. While its primary application is within oncology, Soranib has also garnered attention in the realm of sports pharmacology due to its potential effects on muscle growth and fitness enhancement. Bodybuilders and athletes are exploring its properties for improving overall performance and achieving a competitive edge.
Effect on muscle growth Processes involved
The influence of Soranib 200 mg Cipla on muscle growth is rooted in its mechanism of action. Sorafenib inhibits the pathways that typically regulate cell proliferation and apoptosis, which can create an environment conducive to muscle hypertrophy. Its role in reducing the activity of specific kinases involved in the cell cycle is particularly significant. By blocking these pathways, athletes may experience a reduction in muscle breakdown during intense training, allowing more time for muscle recovery and growth. Furthermore, Soranib has been noted to enhance vascularization, which can improve the delivery of nutrients and oxygen to the muscles during workouts, ultimately leading to improved performance.
Moreover, the potential anti-inflammatory effects of Soranib can also contribute to better recovery times. When muscle inflammation is minimized, athletes can engage in more frequent and intense training sessions, which are vital for muscle growth. It is essential to note that while the appeal of Soranib lies in its effects on muscle enhancement, its use should be approached with caution, emphasizing the importance of responsible use and understanding its broader effects on the body.
Optimal dosage Guidelines for safe results
When considering the use of Soranib 200 mg Cipla, determining the optimal dosage is critical for achieving safe and effective results. While the standard dosage for cancer treatment is typically 400 mg daily, athletes might tailor the dosage based on their individual needs, training regimens, and body weight. It is vital to start with the lowest effective dose to assess tolerance and to minimize the risk of adverse effects. Slowly increasing the dosage while monitoring reactions can provide valuable insights into the right level for muscle enhancement.
Consulting with a healthcare professional familiar with sports pharmacology can further ensure an individualized approach, making adjustments based on metabolic responses and specific training goals. It is crucial to prioritize safety and to not exceed recommended dosing limits, as higher concentrations can lead to significant side effects. Consistent monitoring of health markers while using Soranib is advisable to ensure any potentially harmful reactions are quickly addressed.
How to buy Soranib 200 mg Cipla on our website Simple purchase process
Purchasing Soranib 200 mg Cipla is a straightforward process on our website. Firstly, create an account to gain full access to our range of products, including Soranib. Next, navigate to the product page and review the detailed information provided, including dosage and usage guidelines. Once ready to purchase, simply select the quantity desired and add it to your cart. You can continue browsing our catalog or proceed to checkout.
During checkout, you’ll need to enter your shipping and billing information. Our website is equipped with secure payment options, ensuring that your information is kept confidential and safe. After placing the order, you will receive a confirmation email with tracking information, allowing you to monitor the shipment. Our goal is to provide a seamless purchasing experience, ensuring that athletes have quick and convenient access to the products they need.
Safety recommendations How to avoid side effects
Safety is paramount when considering the use of Soranib 200 mg Cipla. To minimize the risk of side effects, it is essential to adhere to recommended dosages and consult a medical professional prior to use. Certain individuals, especially those with pre-existing conditions or those taking other medications, may experience adverse reactions. Regular monitoring of health parameters, such as liver enzymes and kidney function, can provide insight into your body’s response to the drug.
Hydration is also critical when using Soranib, as proper fluid balance can help mitigate some of the drug’s side effects. Maintaining a balanced diet rich in nutrients will support overall health and muscle recovery. Lastly, listening to your body and recognizing any unusual symptoms can be crucial. If adverse effects are experienced, it is vital to seek medical guidance promptly to address any concerns and adjust the use of the medication accordingly. Prioritizing health and safety ensures that athletes can enjoy the benefits of Soranib while minimizing potential risks.
| Active substance | Sorafenib |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Yes, can cause liver injury |
| Lab Test | Liver function tests are recommended |
| Strength | 200mg |
| Also known as | BAY 43-9006 |
| Blood pressure | Can cause hypertension |
| Trade name | Nexavar |
| Storage conditions | Store at room temperature, protect from moisture |
| Chemical name | 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpyridine-2-carboxamide |
| Formula | C21H16ClF3N4O3 |
| Substance class | Kinase inhibitor |
| Main action | Antineoplastic agent |
| Half-life | Approximately 25 to 48 hours |
| Dosage (medical) | Typically 400 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Inhibits tumor cell proliferation and angiogenesis |
| Side effects | Diarrhea, rash, fatigue, hypertension, hand-foot skin reactions |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 30 tabs/bottle |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.